nodes	percent_of_prediction	percent_of_DWPC	metapath
Pranlukast—TNF—glaucoma	0.592	1	CbGaD
Pranlukast—CYP2C9—Diclofenamide—glaucoma	0.0403	0.167	CbGbCtD
Pranlukast—CYP2C9—Dorzolamide—glaucoma	0.039	0.162	CbGbCtD
Pranlukast—CYP2C9—Methazolamide—glaucoma	0.0347	0.144	CbGbCtD
Pranlukast—CYP3A4—Pilocarpine—glaucoma	0.0299	0.124	CbGbCtD
Pranlukast—CYP3A4—Brinzolamide—glaucoma	0.0235	0.0973	CbGbCtD
Pranlukast—CYP3A4—Dorzolamide—glaucoma	0.0227	0.094	CbGbCtD
Pranlukast—CYP3A4—Methazolamide—glaucoma	0.0202	0.0838	CbGbCtD
Pranlukast—CYP3A4—Acetazolamide—glaucoma	0.0161	0.067	CbGbCtD
Pranlukast—CYP3A4—Clonidine—glaucoma	0.0146	0.0606	CbGbCtD
Pranlukast—TNF—Apoptosis—CDKN2A—glaucoma	0.000129	0.00077	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—BDNF—glaucoma	0.000128	0.000768	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—NCK2—glaucoma	0.000128	0.000767	CbGpPWpGaD
Pranlukast—ABCC2—NRF2 pathway—GSTM1—glaucoma	0.000128	0.000765	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—FN1—glaucoma	0.000127	0.000761	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—NGFR—glaucoma	0.000127	0.000757	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	0.000127	0.000757	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—HEYL—glaucoma	0.000125	0.00075	CbGpPWpGaD
Pranlukast—NFKB1—Senescence-Associated Secretory Phenotype (SASP)—CDKN1B—glaucoma	0.000125	0.000749	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—SOD1—glaucoma	0.000125	0.000748	CbGpPWpGaD
Pranlukast—NFKB1—Downstream signaling events of B Cell Receptor (BCR)—BAD—glaucoma	0.000124	0.000741	CbGpPWpGaD
Pranlukast—NFKB1—Signaling events mediated by HDAC Class I—TNF—glaucoma	0.000123	0.000738	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—IL1A—glaucoma	0.000123	0.000738	CbGpPWpGaD
Pranlukast—NFKB1—DNA Damage Response (only ATM dependent)—CDKN1B—glaucoma	0.000121	0.000726	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—TXN—glaucoma	0.000121	0.000726	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—PTGFR—glaucoma	0.000121	0.000726	CbGpPWpGaD
Pranlukast—TNF—SIDS Susceptibility Pathways—NGF—glaucoma	0.000121	0.000723	CbGpPWpGaD
Pranlukast—TNF—SIDS Susceptibility Pathways—NR3C1—glaucoma	0.00012	0.00072	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—NTRK1—glaucoma	0.00012	0.000719	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—NCK2—glaucoma	0.000119	0.000714	CbGpPWpGaD
Pranlukast—NFKB1—Fc epsilon receptor (FCERI) signaling—BAD—glaucoma	0.000118	0.000708	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—CDKN2B—glaucoma	0.000118	0.000707	CbGpPWpGaD
Pranlukast—TNF—Apoptosis—FAS—glaucoma	0.000117	0.000701	CbGpPWpGaD
Pranlukast—CYP3A4—Tryptophan metabolism—CYP1B1—glaucoma	0.000117	0.000698	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	0.000117	0.000698	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR ligand binding—C3—glaucoma	0.000116	0.000695	CbGpPWpGaD
Pranlukast—CYP2C9—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000116	0.000694	CbGpPWpGaD
Pranlukast—TNF—Selenium Micronutrient Network—PTGS2—glaucoma	0.000116	0.000694	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	0.000116	0.000693	CbGpPWpGaD
Pranlukast—NFKB1—Oncostatin M Signaling Pathway—TP53—glaucoma	0.000115	0.00069	CbGpPWpGaD
Pranlukast—NFKB1—Transcriptional regulation of white adipocyte differentiation—TNF—glaucoma	0.000114	0.000684	CbGpPWpGaD
Pranlukast—NFKB1—Folate Metabolism—TP53—glaucoma	0.000114	0.000682	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—NGF—glaucoma	0.000114	0.000682	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—IL1A—glaucoma	0.000113	0.000674	CbGpPWpGaD
Pranlukast—NFKB1—Rac1/Pak1/p38/MMP-2 pathway—TP53—glaucoma	0.000113	0.000674	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	0.000111	0.000666	CbGpPWpGaD
Pranlukast—TNF—Apoptosis—BCL2L1—glaucoma	0.000111	0.000662	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—LRP12—glaucoma	0.00011	0.000659	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—FAS—glaucoma	0.00011	0.000657	CbGpPWpGaD
Pranlukast—NFKB1—B Cell Activation—BAD—glaucoma	0.000109	0.000655	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—HDAC9—glaucoma	0.000109	0.000652	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—IL1A—glaucoma	0.000107	0.000643	CbGpPWpGaD
Pranlukast—NFKB1—Apoptosis—TNF—glaucoma	0.000107	0.000638	CbGpPWpGaD
Pranlukast—NFKB1—MicroRNAs in cardiomyocyte hypertrophy—TNF—glaucoma	0.000107	0.000638	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CTSA—glaucoma	0.000106	0.000636	CbGpPWpGaD
Pranlukast—NFKB1—Myometrial Relaxation and Contraction Pathways—NOS3—glaucoma	0.000106	0.000633	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—EDN1—glaucoma	0.000105	0.000627	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—SMO—glaucoma	0.000104	0.00062	CbGpPWpGaD
Pranlukast—NFKB1—Selenium Micronutrient Network—TNF—glaucoma	0.000103	0.000615	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—PAX6—glaucoma	0.000101	0.000607	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—NOS3—glaucoma	0.000101	0.000604	CbGpPWpGaD
Pranlukast—ABCC2—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000101	0.000604	CbGpPWpGaD
Pranlukast—TNF—Apoptosis—BAD—glaucoma	0.0001	0.0006	CbGpPWpGaD
Pranlukast—TNF—Allograft Rejection—VEGFA—glaucoma	9.95e-05	0.000596	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	9.91e-05	0.000593	CbGpPWpGaD
Pranlukast—NFKB1—TNF alpha Signaling Pathway—TNF—glaucoma	9.91e-05	0.000593	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—NGF—glaucoma	9.77e-05	0.000585	CbGpPWpGaD
Pranlukast—NFKB1—Glucocorticoid receptor regulatory network—TP53—glaucoma	9.58e-05	0.000573	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—EDN1—glaucoma	9.51e-05	0.000569	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—RPTOR—glaucoma	9.49e-05	0.000568	CbGpPWpGaD
Pranlukast—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	9.43e-05	0.000565	CbGpPWpGaD
Pranlukast—NFKB1—Apoptosis—TP53—glaucoma	9.4e-05	0.000562	CbGpPWpGaD
Pranlukast—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	9.31e-05	0.000557	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—NCK2—glaucoma	9.19e-05	0.00055	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—PTGS2—glaucoma	9.16e-05	0.000548	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—C3—glaucoma	9.15e-05	0.000548	CbGpPWpGaD
Pranlukast—NFKB1—Toll-like Receptor Signaling Pathway—TNF—glaucoma	9.12e-05	0.000546	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—TXNIP—glaucoma	8.94e-05	0.000535	CbGpPWpGaD
Pranlukast—NFKB1—Cellular Senescence—CDKN2A—glaucoma	8.94e-05	0.000535	CbGpPWpGaD
Pranlukast—NFKB1—Apoptosis Modulation and Signaling—TP53—glaucoma	8.81e-05	0.000527	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—TBK1—glaucoma	8.77e-05	0.000525	CbGpPWpGaD
Pranlukast—TNF—Folate Metabolism—TP53—glaucoma	8.68e-05	0.00052	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—CDKN1B—glaucoma	8.68e-05	0.000519	CbGpPWpGaD
Pranlukast—IL5—Immune System—IL1A—glaucoma	8.64e-05	0.000517	CbGpPWpGaD
Pranlukast—NFKB1—Downstream signaling events of B Cell Receptor (BCR)—CDKN1B—glaucoma	8.63e-05	0.000516	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—SMO—glaucoma	8.52e-05	0.00051	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	8.48e-05	0.000507	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—C3—glaucoma	8.31e-05	0.000497	CbGpPWpGaD
Pranlukast—NFKB1—Fc epsilon receptor (FCERI) signaling—CDKN1B—glaucoma	8.24e-05	0.000493	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	8.18e-05	0.00049	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—BAD—glaucoma	8.06e-05	0.000482	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—MMP9—glaucoma	8.04e-05	0.000481	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—C1QB—glaucoma	7.93e-05	0.000475	CbGpPWpGaD
Pranlukast—NFKB1—Cellular Senescence—CDKN1B—glaucoma	7.92e-05	0.000474	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—HDAC9—glaucoma	7.82e-05	0.000468	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—NTRK2—glaucoma	7.79e-05	0.000466	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Breast Cancer Pathway—VEGFA—glaucoma	7.78e-05	0.000466	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	7.75e-05	0.000464	CbGpPWpGaD
Pranlukast—CYP2C9—Biological oxidations—GSTT1—glaucoma	7.73e-05	0.000463	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—PAX6—glaucoma	7.72e-05	0.000462	CbGpPWpGaD
Pranlukast—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	7.65e-05	0.000458	CbGpPWpGaD
Pranlukast—NFKB1—DNA Damage Response (only ATM dependent)—TP53—glaucoma	7.63e-05	0.000457	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—OPN4—glaucoma	7.63e-05	0.000457	CbGpPWpGaD
Pranlukast—NFKB1—B Cell Activation—CDKN1B—glaucoma	7.62e-05	0.000456	CbGpPWpGaD
Pranlukast—IL5—Immune System—C3—glaucoma	7.59e-05	0.000454	CbGpPWpGaD
Pranlukast—NFKB1—SIDS Susceptibility Pathways—VEGFA—glaucoma	7.58e-05	0.000454	CbGpPWpGaD
Pranlukast—TNF—Alzheimers Disease—TP53—glaucoma	7.52e-05	0.00045	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—EDN1—glaucoma	7.52e-05	0.00045	CbGpPWpGaD
Pranlukast—CYP2C9—Arachidonic acid metabolism—PTGS2—glaucoma	7.46e-05	0.000446	CbGpPWpGaD
Pranlukast—ABCC2—Transmembrane transport of small molecules—SLC6A1—glaucoma	7.39e-05	0.000442	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—VEGFA—glaucoma	7.27e-05	0.000435	CbGpPWpGaD
Pranlukast—IL5—Immune System—BCL2L1—glaucoma	7.27e-05	0.000435	CbGpPWpGaD
Pranlukast—TNF—Apoptosis—TP53—glaucoma	7.16e-05	0.000428	CbGpPWpGaD
Pranlukast—NFKB1—Regulation of toll-like receptor signaling pathway—TNF—glaucoma	7.12e-05	0.000426	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—HEYL—glaucoma	7.09e-05	0.000424	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—TXN—glaucoma	7.07e-05	0.000423	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—PTGFR—glaucoma	6.87e-05	0.000411	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—EDN1—glaucoma	6.83e-05	0.000409	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—CDKN2A—glaucoma	6.75e-05	0.000404	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—NGFR—glaucoma	6.69e-05	0.0004	CbGpPWpGaD
Pranlukast—IL5—Immune System—BAD—glaucoma	6.59e-05	0.000394	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—C3—glaucoma	6.57e-05	0.000393	CbGpPWpGaD
Pranlukast—NFKB1—SIDS Susceptibility Pathways—TNF—glaucoma	6.49e-05	0.000389	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	6.44e-05	0.000386	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—NTRK1—glaucoma	6.35e-05	0.00038	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	6.23e-05	0.000373	CbGpPWpGaD
Pranlukast—CYP2C9—Biological oxidations—CYP1B1—glaucoma	6.16e-05	0.000369	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—TNF—glaucoma	6.12e-05	0.000366	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—SMO—glaucoma	6.12e-05	0.000366	CbGpPWpGaD
Pranlukast—CYP2C9—Metapathway biotransformation—CYP1B1—glaucoma	6.08e-05	0.000364	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—CDKN1B—glaucoma	5.98e-05	0.000358	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—C3—glaucoma	5.96e-05	0.000357	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	5.9e-05	0.000353	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Breast Cancer Pathway—TP53—glaucoma	5.88e-05	0.000352	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—CDKN2B—glaucoma	5.86e-05	0.00035	CbGpPWpGaD
Pranlukast—TNF—SIDS Susceptibility Pathways—VEGFA—glaucoma	5.77e-05	0.000346	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—CTSA—glaucoma	5.75e-05	0.000344	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—EDN1—glaucoma	5.62e-05	0.000336	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—CDKN1B—glaucoma	5.61e-05	0.000336	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—NTRK2—glaucoma	5.59e-05	0.000335	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	5.52e-05	0.000331	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—TP53—glaucoma	5.5e-05	0.000329	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—TP53—glaucoma	5.45e-05	0.000326	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—CA5A—glaucoma	5.42e-05	0.000324	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—NARFL—glaucoma	5.42e-05	0.000324	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—TP53—glaucoma	5.4e-05	0.000323	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—RPTOR—glaucoma	5.37e-05	0.000322	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—C3—glaucoma	5.3e-05	0.000317	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—NCK2—glaucoma	5.2e-05	0.000312	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—NGF—glaucoma	5.16e-05	0.000309	CbGpPWpGaD
Pranlukast—CYP3A4—Biological oxidations—GSTT1—glaucoma	5.1e-05	0.000305	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—C3—glaucoma	5.09e-05	0.000304	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—BCL2L1—glaucoma	5.07e-05	0.000303	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—VEGFA—glaucoma	4.97e-05	0.000298	CbGpPWpGaD
Pranlukast—NFKB1—Cellular Senescence—TP53—glaucoma	4.97e-05	0.000298	CbGpPWpGaD
Pranlukast—CYP2C9—Biological oxidations—GSTM1—glaucoma	4.92e-05	0.000295	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	4.91e-05	0.000294	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—C3—glaucoma	4.91e-05	0.000294	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	4.87e-05	0.000291	CbGpPWpGaD
Pranlukast—CYP2C9—Metapathway biotransformation—GSTM1—glaucoma	4.86e-05	0.000291	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—NGFR—glaucoma	4.8e-05	0.000287	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—BAD—glaucoma	4.59e-05	0.000275	CbGpPWpGaD
Pranlukast—IL5—Immune System—CDKN1B—glaucoma	4.59e-05	0.000275	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—APOE—glaucoma	4.57e-05	0.000273	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—NTRK1—glaucoma	4.56e-05	0.000273	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—CAV1—glaucoma	4.53e-05	0.000271	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—MMP2—glaucoma	4.46e-05	0.000267	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—HDAC9—glaucoma	4.43e-05	0.000265	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—BAD—glaucoma	4.41e-05	0.000264	CbGpPWpGaD
Pranlukast—TNF—Apoptosis—TP53—glaucoma	4.38e-05	0.000262	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—FN1—glaucoma	4.31e-05	0.000258	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—BAD—glaucoma	4.26e-05	0.000255	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CDKN2B—glaucoma	4.2e-05	0.000252	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—TP53—glaucoma	4.11e-05	0.000246	CbGpPWpGaD
Pranlukast—CYP3A4—Biological oxidations—CYP1B1—glaucoma	4.06e-05	0.000243	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—EDN1—glaucoma	4.03e-05	0.000241	CbGpPWpGaD
Pranlukast—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	4.01e-05	0.00024	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—TP53—glaucoma	3.76e-05	0.000225	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	3.71e-05	0.000222	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—NGF—glaucoma	3.71e-05	0.000222	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—CA5A—glaucoma	3.57e-05	0.000214	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—NARFL—glaucoma	3.57e-05	0.000214	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—C3—glaucoma	3.52e-05	0.000211	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—IL1A—glaucoma	3.51e-05	0.00021	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—SMO—glaucoma	3.46e-05	0.000207	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—NOS3—glaucoma	3.42e-05	0.000205	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—MMP2—glaucoma	3.4e-05	0.000204	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—MMP9—glaucoma	3.36e-05	0.000201	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—APOE—glaucoma	3.28e-05	0.000196	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CAV1—glaucoma	3.25e-05	0.000194	CbGpPWpGaD
Pranlukast—CYP3A4—Biological oxidations—GSTM1—glaucoma	3.25e-05	0.000194	CbGpPWpGaD
Pranlukast—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	3.2e-05	0.000192	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—CDKN1B—glaucoma	3.2e-05	0.000192	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—NTRK2—glaucoma	3.17e-05	0.00019	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—FN1—glaucoma	3.09e-05	0.000185	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—C3—glaucoma	3.08e-05	0.000185	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—CDKN1B—glaucoma	3.07e-05	0.000184	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—BAD—glaucoma	3.06e-05	0.000183	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—VEGFA—glaucoma	3.01e-05	0.00018	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—CDKN1B—glaucoma	2.97e-05	0.000177	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—BCL2L1—glaucoma	2.95e-05	0.000177	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—MMP9—glaucoma	2.75e-05	0.000164	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—NGFR—glaucoma	2.72e-05	0.000163	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—BAD—glaucoma	2.68e-05	0.00016	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—CA1—glaucoma	2.65e-05	0.000158	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—TNF—glaucoma	2.58e-05	0.000155	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—NTRK1—glaucoma	2.58e-05	0.000155	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—CTSA—glaucoma	2.56e-05	0.000153	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—MMP9—glaucoma	2.56e-05	0.000153	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—VEGFA—glaucoma	2.47e-05	0.000148	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—NOS3—glaucoma	2.46e-05	0.000147	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—CA2—glaucoma	2.42e-05	0.000145	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CDKN2B—glaucoma	2.38e-05	0.000142	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	2.37e-05	0.000142	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	2.37e-05	0.000142	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—VEGFA—glaucoma	2.3e-05	0.000137	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—EDN1—glaucoma	2.28e-05	0.000137	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CDKN1B—glaucoma	2.13e-05	0.000127	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—NGF—glaucoma	2.1e-05	0.000126	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—C3—glaucoma	1.99e-05	0.000119	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—MMP9—glaucoma	1.97e-05	0.000118	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CDKN1B—glaucoma	1.86e-05	0.000112	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—TP53—glaucoma	1.86e-05	0.000112	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—APOE—glaucoma	1.86e-05	0.000111	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CAV1—glaucoma	1.84e-05	0.00011	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—VEGFA—glaucoma	1.77e-05	0.000106	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—FN1—glaucoma	1.75e-05	0.000105	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—CA1—glaucoma	1.75e-05	0.000104	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—BAD—glaucoma	1.73e-05	0.000104	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—TXN—glaucoma	1.71e-05	0.000102	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—CTSA—glaucoma	1.69e-05	0.000101	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—CA2—glaucoma	1.6e-05	9.55e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.56e-05	9.31e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.54e-05	9.23e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—NOS3—glaucoma	1.39e-05	8.33e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—TP53—glaucoma	1.34e-05	8e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—GSTT1—glaucoma	1.32e-05	7.91e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CDKN1B—glaucoma	1.21e-05	7.21e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—TXN—glaucoma	1.12e-05	6.73e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—MMP9—glaucoma	1.12e-05	6.68e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.07e-05	6.38e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—ABCA1—glaucoma	1.05e-05	6.31e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—CYP1B1—glaucoma	1.05e-05	6.31e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—VEGFA—glaucoma	1e-05	6e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—GSTT1—glaucoma	8.72e-06	5.22e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—GSTM1—glaucoma	8.42e-06	5.04e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—TP53—glaucoma	7.57e-06	4.53e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—MTHFR—glaucoma	7.44e-06	4.45e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—ABCA1—glaucoma	6.95e-06	4.16e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—CYP1B1—glaucoma	6.95e-06	4.16e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—APOE—glaucoma	6.93e-06	4.15e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—CAV1—glaucoma	6.87e-06	4.11e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—GSTM1—glaucoma	5.55e-06	3.32e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—NOS3—glaucoma	5.19e-06	3.11e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—MTHFR—glaucoma	4.91e-06	2.94e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PTGS2—glaucoma	4.75e-06	2.84e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—APOE—glaucoma	4.57e-06	2.74e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—CAV1—glaucoma	4.53e-06	2.71e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—NOS3—glaucoma	3.42e-06	2.05e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PTGS2—glaucoma	3.13e-06	1.87e-05	CbGpPWpGaD
